What's New

• 28 Mar 2019
  Antares Pharma Announces Receipt of Orphan Drug Designation For The Treatment of Ectopic Pregnancy With Methotrexate Read More

• 04 Mar 2019
  Dr. Karen Smith joins the Antares board Read More

• 28 Feb 2019
  ANTARES PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2018 OPERATING AND FINANCIAL RESULTS Read More